Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |